Combined targeting of EGFR and HER2 against prostate cancer stem cells

Progression of prostate cancer has been associated with EGFR and HER2 activation and to tumor-initiating cells contribution toward chemotherapy resistance. We investigated the efficacy of a dual intervention against EGFR and HER2 to deplete the tumor-initiating cells, optimize the chemotherapy manag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Ther
Autors principals: Rossini, Anna, Giussani, Marta, Ripamonti, Francesca, Aiello, Piera, Regondi, Viola, Balsari, Andrea, Triulzi, Tiziana, Tagliabue, Elda
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515488/
https://ncbi.nlm.nih.gov/pubmed/32089070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1727702
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars